Last reviewed · How we verify
NCT03716999
Starlight Therapy in Palliative Care
trial testing Starlight Therapy in Symptom Management in 100 participants. Not yet recruiting.
30 November 2027
Quick facts
| Lead sponsor | Nova Scotia Health Authority |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 15 December 2026 |
| Primary completion | 30 November 2027 |
| Estimated completion | 30 November 2027 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Starlight Therapy
Conditions studied
- Symptom Management — all drugs for Symptom Management →
Sponsor
Nova Scotia Health Authority — full company profile →
Who can join
Eligibility, any sex, with Symptom Management. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Starlight Therapy™ has been shown to help alleviate end-of-life symptoms in Palliative Care patients and reduce the need for PRN or "as needed" medications. This study will investigate the efficacy of this intervention on the symptom of anxiety using a mixed-method analysis. The primary investigator hypothesizes that any anti-anxiolytic effects could be caused by the Intrinsically Photosensitive Retinal Ganglion Cell neural pathway to the amygdala.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03716999
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Symptom Management
Currently open trials in the same condition.
- NCT07332377 — mHealth Intervention for Pain Self Management · NA · recruiting
- NCT06903052 — Nurse Parental Support Using a Proactive Mobile App in Symptom Management for Children With Mechanical Ventilation · NA · recruiting
- NCT06707649 — The Effectiveness of Self-Management Education and Telephone Follow-up in Patient with COPD Exacerbation · NA · recruiting
- NCT07411508 — The Effects of Face-to-face and Tele-nursing Education on Fatigue, Pain, Sleep, and Urinary Tract Infections in Patients · NA · active not recruiting
- NCT06434545 — Symptom Management Essentials at Home · NA · active not recruiting
Other Nova Scotia Health Authority trials
Trials by the same sponsor.
- NCT06987409 — Continuous Erector Spinae Block for Analgesia Following Lumbar Decompression · NA · not yet recruiting
- NCT06575621 — Knee-hip Surgery Wait-list Support Program · NA · not yet recruiting
- NCT07143162 — YOGA-FIT: Protocol for a Crossover Trial Investigating the Feasibility and Impact of Yoga for People With Stroke · NA · not yet recruiting
- NCT07239999 — Comparing Spinal Anesthesia With 1% Chloroprocaine Versus 1% Mepivacaine in Patients Undergoing Outpatient Primary Total · Phase 4 · not yet recruiting
- NCT07056894 — Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03716999 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nova Scotia Health Authority
- Last refreshed: 23 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03716999.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing